Lymph microvascularization as a prognostic indicator in neuroblastoma.

about

Lymph microvascularization as a prognostic indicator in neuroblastoma.

Item

http://www.wikidata.org/entity/Q55241229

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

Lymph microvascularization as a prognostic indicator in neuroblastoma.

@en

Lymph microvascularization as a prognostic indicator in neuroblastoma.

@nl

type

Item

label

Lymph microvascularization as a prognostic indicator in neuroblastoma.

@en

Lymph microvascularization as a prognostic indicator in neuroblastoma.

@nl

prefLabel

Lymph microvascularization as a prognostic indicator in neuroblastoma.

@en

Lymph microvascularization as a prognostic indicator in neuroblastoma.

@nl

P1476

Lymph microvascularization as a prognostic indicator in neuroblastoma

@en

P2093

Adela Cañete

http://www.w3.org/2001/XMLSchema#string

Esther Gamero-Sandemetrio

http://www.w3.org/2001/XMLSchema#string

Félix Ritort

http://www.w3.org/2001/XMLSchema#string

Irene Tadeo

http://www.w3.org/2001/XMLSchema#string

Rosa Noguera

http://www.w3.org/2001/XMLSchema#string

Samuel Navarro

http://www.w3.org/2001/XMLSchema#string

P2860

LYVE-1, a new homologue of the CD44 glycoprotein, is a lymph-specific receptor for hyaluronan

Epidemiology of childhood cancer

Antiangiogenic therapy elicits malignant progression of tumors to increased local invasion and distant metastasis

Highly sensitive method for genomewide detection of allelic composition in nonpaired, primary tumor specimens by use of affymetrix single-nucleotide-polymorphism genotyping microarrays

Interstitial fluid and lymph formation and transport: physiological regulation and roles in inflammation and cancer

Angiogenesis in cancer and other diseases

High interstitial fluid pressure - an obstacle in cancer therapy

Vascular normalization as a therapeutic strategy for malignant and nonmalignant disease.

Molecular biology of neuroblastoma.

Targeting VEGFR-3/-2 signaling pathways with AD0157: a potential strategy against tumor-associated lymphangiogenesis and lymphatic metastases.

P304

26157-26170

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.18632/ONCOTARGET.25457

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Gloria Bueno

Ana P Berbegall

Marta Gironella

P577

2018-05-25T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29899849

http://www.w3.org/2001/XMLSchema#string

P932

5995242

http://www.w3.org/2001/XMLSchema#string